CSPI targets juice capsules
This article was originally published in The Tan Sheet
Executive Summary
FDA should halt the marketing of NSA's Juice Plus+ Orchard Blend and Juice Plus+ Garden Blend capsules because the products appear to be adulterated and misbranded, the Center for Science in the Public Interest says in a letter to the agency Dec. 12. CSPI says it is concerned the products' claim, "the next best thing to fruits and vegetables," may lead consumers to believe the pills are "closer to real fruits and vegetables than is likely to be the case." The labels say the capsules contain high levels of vitamins A and C and folate naturally, and do not disclose that these vitamins and minerals are added to the capsules during processing and are nutrients only characteristic of the original fruit and vegetable sources...
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.